| Literature DB >> 25566455 |
Hyun Jin Yoo1, Geun Hoon Choi1, Man Gyoon Lee2, Chang Kyun Kang2, Hyon Park1.
Abstract
PURPOSE: Various kinds of food substances from all over the world have been proposed to use as ergogenic aids for the additional improvement of exercise performance especially in athletes. Herb medicine which usually being applied for the cure of disease is used as a performance booster in several far eastern countries including Korea. Many scientists and coaches have asked very objective verifications on the reality of herb medicines practically used but never been scientifically elucidated well enough. In addition to the possibility as an ergogenic aid, the safety in doping is the critical factor to be examined thoroughly. In this study, Sibjeondaebo-Tang, a leading popular prescribed herb medicine in Korea, was examined.Entities:
Keywords: Doping; Sibjeondaebo-Tang; Taekwondo; ergogenic aid
Year: 2014 PMID: 25566455 PMCID: PMC4241916 DOI: 10.5717/jenb.2014.18.2.189
Source DB: PubMed Journal: J Exerc Nutrition Biochem ISSN: 2233-6834
Physical characteristics of subjects
| Subjects | 1 | 2 | 3 | 4 | 5 | 6 | Mean ± SD |
|---|---|---|---|---|---|---|---|
| Sex | M | M | M | M | M | M | |
| Age (years) | 20 | 20 | 20 | 20 | 20 | 20 | 20±0.00 |
| Height (cm) | 175.5 | 170.7 | 172.5 | 174.8 | 184.8 | 174.5 | 175.47±4.90 |
| Weight (kg) | 74.7 | 63.4 | 69.6 | 64.6 | 78.0 | 66.4 | 69.45±5.83 |
| Muscle Mass (kg) | 56.4 | 49.6 | 53.0 | 49.8 | 58.1 | 51.8 | 53.12±3.49 |
| Percent Body Fat (%) | 18.7 | 15.8 | 18.0 | 17.0 | 19.6 | 16.1 | 17.53±1.50 |
Fig. 1.Procedure of experiment
Changes of blood lactate according to taking herbal medicine (mmol/L)
| Groups | pre | post | post 30 min | P | |
|---|---|---|---|---|---|
| Lactate | Control | 1.42±0.31 | 3.50±0.78a | 1.84±0.85 | T:0.224 |
| Placebo | 1.75±0.51 | 3.45±0.78b | 1.97±0.37 | T × G:0.676 | |
| Sibjeondaebo-Tang | 1.53±0.30 | 2.45±0.22ab | 1.54±0.41 | G:0.035 |
Mean ± SD,
p < .05,
p < .01,
p < .001 level.
Same alphabet indicates significant difference by LSD.
T: time, G:group, T × G:interaction.
Urine specimen analysis results according to Sibjeondaebo-Tang intake
| Subject | Result | |||
|---|---|---|---|---|
| Anabolic agents | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
| Agents with anti-estrogenic activity | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
| Narcotics | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
| Beta-2 agonists | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
| Stimulants | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
| Hormone and related substances | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
| Diuretics and other masking agents | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
| Cannabinoids | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
| Glucocortico-steroids | Subject 1 | (negative) | Subject 4 | (negative) |
| Subject 2 | (negative) | Subject 5 | (negative) | |
| Subject 3 | (negative) | Subject 6 | (negative) | |
Changes of VO2max according to herbal medicine intake (ml/kg/min).
| Control | Placebo | Sibjeondaebo-Tang | F | P | |
|---|---|---|---|---|---|
| VO2max | 48.67±6.80 | 48.83±3.76 | 45.33±3.93 | .924 | .418 |
Mean ± SD
Subjective condition according to Sibjeondaebo-Tang or placebo (%).
| Fatigue | Digestive condition | Bowel condition | Conditions | |||||
|---|---|---|---|---|---|---|---|---|
| Sibjeondaebo-Tang | placebo | Sibjeondaebo-Tang | placebo | Sibjeondaebo-Tang | placebo | Sibjeondaebo-Tang | placebo | |
| Not very good | 0 | 0 | 0 | 0 | 16.7 | 0 | 0 | 0 |
| Not Good | 33.3 | 50.0 | 50.0 | 16.7 | 16.7 | 16.7 | 50.0 | 0 |
| Usually | 66.7 | 33.3 | 33.3 | 33.3 | 33.3 | 50.0 | 33.3 | 50.0 |
| Good | 0 | 16.7 | 16.7 | 33.3 | 33.3 | 33.3 | 16.7 | 50.0 |
| Very Good | 0 | 0 | 0 | 16.7 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |